SkinHealth Systems shares are trading higher after the company announced it secured FDA clearance for its SkinStylus microneedling device for periorbital wrinkles in adults for all Fitzpatrick skin types.

Benzinga Newsdesk www.benzinga.com Positive 95.4%

Neg 0% Neu 0% Pos 95.4%

Comments

No comments yet. Be the first!